SHMT2 and central nervous system cancer: ,22,23 Specifically, SHMT2 is required for glioma cell survival and promotes changes in metabolism that allow tumor cells to adapt to the environment; thus, preventing endogenous glycine production via SHMT2 inhibition is desired as an efficient therapy for tumorigenesis.24